MediNex

 

On Jan 18, MediNex $ Medinex: OTX 0% non-executive chairman Tan Lee Meng acquired 416,300 shares of the Catalist-listed company at an average price of 22.5 cents per share.

 

With a consideration of S$93,668, this took his direct interest in the company from 8.92 per cent to 9.24 per cent.

 

For its H1FY22 (ended Sep 30) MediNex reported that its profit before income tax increased by 43.18 per cent to S$2.29 million.

 

Together with its subsidiaries, MediNex is a Singapore-based medical support services provider, specialising in providing professional support services to medical clinics.

 

Tan has more than 20 years of experience in business development, incubating and investing in companies, and project management.

 

He was also previously an independent director of BRC Asia and Hisaka Holdings (now known as Regal International Group), and a non-executive director of See Hup Seng now known as SHS Holdings and Sibercert (a subsidiary of PSB Corporation).